Back to Stakeholders

The Nielson Lab at the University of Minnesota is dedicated to understanding and treating trauma. More recently, the team here has been diving into psychedelic neuroscience research and drug policy reform thanks to funding from the newly created Psychedelic-Assisted THerapy (PATH) Fund at the UMN Foundation. The lab has been collecting survey data to assess the benefits and risks of ayahuasca use in naturalistic settings to treat symptoms of trauma. Additionally, Dr Jessica Nielson and her team are researching the neurological mechanisms of altered states of consciousness and their role in promoting neuroplasticity and wellness in healthy research participants.

Academic Research

0 papers

Published Papers

0

Trial Involvement

4

Distinct Focus Topics

0

Latest Publication

Unknown

Quick Facts

Type
academic
HQ
United States
Website
Visit

Research Landscape

What the 4 registered trials University of Minnesota sponsors or participates in look like when you line them up. Counts come from Blossom’s trial records as of July 2026.

What's live right now, and what stopped?

Sourced

Registry status of all 4 University of Minnesota trials Blossom tracks. Orange marks trials recruiting or opening.

Completed
375%
Stopped early
125%

Don't read stopped trials as failures: trials end early for funding, recruitment, and strategy reasons too. Status is as last synced from the registry; some 'recruiting' trials may already have finished.

Sponsored Trials

3

Collaborated Trials

1